Acute Kidney Injury in Coronavirus Disease-19 (COVID-19) Patients Admitted to the Intensive Care Unit (ICU)

Summary

The aim of this study is to evaluate the rate and outcomes of COVID-19 associated acute kidney injury (AKI) and use of kidney replacement therapy (KRT) in critically ill COVID-19 patients in ICUs in several large hospitals in Flanders, the northern region of Belgium. We will also explore the associations between several baseline risk factors for AKI, therapeutic strategies and COVID-19 related clinical signs and the occurrence of AKI and use of KRT.

Conditions

• Critical Illness
• COVID-19 Pneumonia
• Acute Kidney Injury

Interventions

OTHER

Observational study exploring the epidemiology and outcomes of AKI in critical COVID-19 patients admitted to the ICU

Critical COVID-19 patients admitted to the ICU

Sponsors & Collaborators

• Universitaire Ziekenhuizen KU Leuven

  collaborator OTHER

• University Hospital, Antwerp

  collaborator OTHER

• Ziekenhuis Oost-Limburg

  collaborator OTHER

• Jessa Hospital

  collaborator OTHER

• General Hospital Groeninge

  collaborator OTHER

• AZ Delta

  collaborator OTHER

• AZ Turnhout

  collaborator OTHER

• AZ Sint-Jan AV

  collaborator OTHER

• University Hospital, Ghent

  lead OTHER

Principal Investigators

• Eric Hoste, Md, PhD · University Hospital, Ghent

• Greet De Vlieger, Md, PhD · Universitaire Ziekenhuizen KU Leuven

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-02-01

Primary Completion

2021-06-01

Completion

2022-05-17

Countries

• Belgium

Study Locations